Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...
Amivantamab with lazertinib will be made available on the NHS. This will provide a possible treatment for people with a ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Primary endpoint ARIGA improved by ~50% from baseline by Week 6, with all evaluable patients reaching low-severity disease; additional endpoints demonstrated ~34% improvement ...
A novel cancer treatment will be accessible on the NHS following 'careful consideration of the evidence' by the National ...
Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...
Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.
Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene ...
Advances in lung cancer treatment have changed survival in ways that were unimaginable even a decade ago. Targeted drugs, ...
National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback